Celadon Pharmaceuticals (LON:CEL – Free Report) had its price objective upped by Canaccord Genuity Group from GBX 210 ($2.56) to GBX 235 ($2.87) in a research report report published on Friday morning, MarketBeat reports. They currently have a speculative buy rating on the stock. Separately, Canaccord Genuity Group reaffirmed a speculative buy rating and set […]
Hemogenyx Pharmaceuticals (LON:HEMO) Shares Up 30 5% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Celadon Pharmaceuticals (LON:CEL) Trading 3 7% Higher kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.